Envolvimento de neurotransmissões angiotensinérgicas no núcleo medial da amídala nas respostas cardiovasculares e ansiogênica ao estresse de restrição em ratos

Detalhes bibliográficos
Autor(a) principal: Costa-Ferreira, Willian
Data de Publicação: 2020
Tipo de documento: Tese
Idioma: por
Título da fonte: Repositório Institucional da UFSCAR
Texto Completo: https://repositorio.ufscar.br/handle/ufscar/13362
Resumo: Limbic structures participate in the control of physiological responses related to stress, and the medial amigdaloid nucleus (MeA) has been demonstrated as an area of the central nervous system involved in the control these responses. The angiotensin II, acting on the AT1 receptor, has been shown to be an important signaling mechanism in the central nervous system involved in the etiology of behavioral changes and in the physiological adjustments observed during aversive situations, whereas the AT2 receptor and the angiotensin 1-7/Mas receptor neutranmission acts as a mechanism against regulation of the AT1 receptor. Thus, the hypothesis of our work was that cardiovascular and anxiogenic changes to restraint stress (RS) are modulated by angiotensin II/ AT1 receptor, AT2 and angiotensin 1-7 / Mas receptor neurotransmission in the AMe. In the characterization the role of angiotensinergic neurotransmissions in the MeA in the baroreflex control activity in non-stressed animals indicated that the AT2 receptor in MeA plays an inhibitory role in the tachycardia reflex response, but without affecting bradycardia reflex; whereas the Mas receptor has a facilitating influence on both tachycardia and bradycardia reflex. In experiments on cardiovascular function of exposure to a 10-days of RS, this protocol caused an increase in arterial pressure baseline, facilitated tachycardic reflex and impaired spontaneous baroreflex activity. The animals treated with losartan attenuated tachycardia reflex, whereas the other changes were not affected by treatments. In the experiment comparing the effects of the MeA pharmacological treatments with angiotensinergic receptors agonists and antagonists on cardiovascular responses during an acute session and the 10th RS session, we found that repeated exposure to RS abolished facilitation of tachycardic response caused by the treatment of the MeA with angiotensin II and losartan in acute stressed animals. The tachycardic reduction caused by A-779 and the pressor response in animals treated with PD123319 in animals that were acutely stressed, was inhibited after repeated exposure to RS. In addition, repeated exposure to RS reversed the reduction in tachycardic response caused by MeA treatment with PD123319 seen in acutely stressed animals. Was not observed effect on facilitation of the tachycardic response after repeated exposure to RS by angiontensin 1-7 microinjection in the MeA. The reduction in the skin's tail temperature was greater in chronically stressed animals, and only treatment with PD123319 inhibited this facilitation. In the anxiogenic response, animals that went through an acute session showed behavioral of the anxiogenic type, and treatments with angiotensin II, losartan and angiotensin 1-7 inhibited this effect. Anxiogenic effect was also observed 24h after the 9th restraint session, and without additional five minutes after the 10th restraint session. In addition, the pharmacological treatments of the MeA did not cause any behavioral changes in the EPM in animals repeatedly exposed to RS. Finally, we identified that repeated exposure to RS increased the expression of the AT1 receptor and decreased the expression of the Mas receptor in the MeA. In short, our data support an involvement of RAS present in MeA in the control of cardiovascular and behavioral responses to stress, and this control seems to beinfluenced by previous experience with the stressor.
id SCAR_564c952b3d6a1962391f562807f738c6
oai_identifier_str oai:repositorio.ufscar.br:ufscar/13362
network_acronym_str SCAR
network_name_str Repositório Institucional da UFSCAR
repository_id_str 4322
spelling Costa-Ferreira, WillianCrestani, Carlos Cesarhttp://lattes.cnpq.br/1117432571971568http://lattes.cnpq.br/1826719696228199c714f15c-534b-4a9f-a5af-9f7c04a4bc102020-10-22T14:28:48Z2020-10-22T14:28:48Z2020-09-04COSTA-FERREIRA, Willian. Envolvimento de neurotransmissões angiotensinérgicas no núcleo medial da amídala nas respostas cardiovasculares e ansiogênica ao estresse de restrição em ratos. 2020. Tese (Doutorado em Ciências Fisiológicas) – Universidade Federal de São Carlos, São Carlos, 2020. Disponível em: https://repositorio.ufscar.br/handle/ufscar/13362.https://repositorio.ufscar.br/handle/ufscar/13362Limbic structures participate in the control of physiological responses related to stress, and the medial amigdaloid nucleus (MeA) has been demonstrated as an area of the central nervous system involved in the control these responses. The angiotensin II, acting on the AT1 receptor, has been shown to be an important signaling mechanism in the central nervous system involved in the etiology of behavioral changes and in the physiological adjustments observed during aversive situations, whereas the AT2 receptor and the angiotensin 1-7/Mas receptor neutranmission acts as a mechanism against regulation of the AT1 receptor. Thus, the hypothesis of our work was that cardiovascular and anxiogenic changes to restraint stress (RS) are modulated by angiotensin II/ AT1 receptor, AT2 and angiotensin 1-7 / Mas receptor neurotransmission in the AMe. In the characterization the role of angiotensinergic neurotransmissions in the MeA in the baroreflex control activity in non-stressed animals indicated that the AT2 receptor in MeA plays an inhibitory role in the tachycardia reflex response, but without affecting bradycardia reflex; whereas the Mas receptor has a facilitating influence on both tachycardia and bradycardia reflex. In experiments on cardiovascular function of exposure to a 10-days of RS, this protocol caused an increase in arterial pressure baseline, facilitated tachycardic reflex and impaired spontaneous baroreflex activity. The animals treated with losartan attenuated tachycardia reflex, whereas the other changes were not affected by treatments. In the experiment comparing the effects of the MeA pharmacological treatments with angiotensinergic receptors agonists and antagonists on cardiovascular responses during an acute session and the 10th RS session, we found that repeated exposure to RS abolished facilitation of tachycardic response caused by the treatment of the MeA with angiotensin II and losartan in acute stressed animals. The tachycardic reduction caused by A-779 and the pressor response in animals treated with PD123319 in animals that were acutely stressed, was inhibited after repeated exposure to RS. In addition, repeated exposure to RS reversed the reduction in tachycardic response caused by MeA treatment with PD123319 seen in acutely stressed animals. Was not observed effect on facilitation of the tachycardic response after repeated exposure to RS by angiontensin 1-7 microinjection in the MeA. The reduction in the skin's tail temperature was greater in chronically stressed animals, and only treatment with PD123319 inhibited this facilitation. In the anxiogenic response, animals that went through an acute session showed behavioral of the anxiogenic type, and treatments with angiotensin II, losartan and angiotensin 1-7 inhibited this effect. Anxiogenic effect was also observed 24h after the 9th restraint session, and without additional five minutes after the 10th restraint session. In addition, the pharmacological treatments of the MeA did not cause any behavioral changes in the EPM in animals repeatedly exposed to RS. Finally, we identified that repeated exposure to RS increased the expression of the AT1 receptor and decreased the expression of the Mas receptor in the MeA. In short, our data support an involvement of RAS present in MeA in the control of cardiovascular and behavioral responses to stress, and this control seems to beinfluenced by previous experience with the stressor.Estruturas límbicas participam do controle de respostas fisiológicas relacionadas ao estresse, e o núcleo medial (AMe) foi demonstrado como uma área encefálica envolvida no controle dessas respostas. A angiotensina II, atuando no receptor AT1, foi demonstrado ser um importante mecanismo de sinalização no sistema nervoso central envolvido nas alterações comportamentais e nos ajustes fisiológicos observados durante situações aversivas, ao passo que o receptor AT2 e a neurotransmissão angiotensina 1-7/receptor Mas atuam como um mecanismo contra-regulatórios para os efeitos pró-estresse do receptor AT1. Assim, a hipótese de nosso trabalho foi que as alterações cardiovasculares e ansiogênica ao estresse de restrição (ER) sejam moduladas pelas neurotransmissões angiotensina II/receptores AT1 e AT2 e angiotensina 1-7/receptor Mas no AMe. Na caracterização do papel das neurotransmissões angiotensinérgicas no AMe no controle da atividade barorreflexa em animais não-estressados indicaram que o receptor AT2 no AMe desempenha um papel inibitório na resposta de taquicardia reflexa, mas sem afetar a bradicardia reflexa, ao passo que o receptor Mas exerce uma influência facilitatória tanto na taquicardia quanto na bradicardia reflexa. No experimento da função cardiovascular após exposição a 10 dias de ER, houve aumento da pressão arterial basal, facilitação da taquicardia reflexa e prejuízo na atividade barorreflexa espontânea. Animais tratados com losartana atenuaram a taquicardia reflexa, ao passo que as demais alterações não foram afetadas pelos tratamentos. No experimento que comparamos os efeitos dos tratamentos farmacológicos do AMe com agonistas e antagonistas de receptores angiotensinérgicos sobre as respostas cardiovasculares durante uma sessão aguda e a 10º sessão de ER, identificamos que a exposição repetida ao ER aboliu a facilitação da resposta taquicárdica causada pelo tratamento do AMe com angiotensina II e losartana nos animais estressados agudamente. A redução da taquicardia causada pelo A-779 e da resposta pressora nos animais tratados com PD123319 em animais estressados agudamente, foi inibida após a exposição repetida ao ER. Além disso, a exposição repetida ao ER inverteu a redução na resposta taquicárdica causada pelo tratamento do AMe com PD123319 em animais estressados agudamente. Não foi observado efeito da facilitação da resposta taquicárdica após exposição repetida ao ER pela microinjeção de angiontensina 1-7 no AMe. A redução da temperatura cutânea da cauda foi maior nos animais estressados cronicamente, e somente o tratamento com PD123319 inibiu essa facilitação. Na resposta ansiogênica, animais que passaram por uma sessão aguda apresentaram comportamento do tipo ansiogênico, e os tratamentos com angiotensina II, losartana e angiotensina 1-7 inibiram esse efeito. Efeito ansiogênico também foi observado 24h após a 9º sessão de restrição, e sem efeito adicional cinco minutos após a 10º sessão de restrição. Além disso, os tratamentos não causaram nenhuma alteração comportamental no LCE nos animais expostos repetidamente ao ER. Por fim, nós identificamos que a exposição repetida ao ER aumentou a expressão do receptor AT1 e diminuiu a expressão do receptor Mas no AMe. Em suma, nossos dados suportam um envolvimento dos SRA presentes no AMe no controle de respostas cardiovasculares e comportamentais ao estresse, e esse controle parece ser influenciado pela experiência prévia ao agente estressor.Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)FAPESP: 2016/05218-2porUniversidade Federal de São CarlosCâmpus São CarlosPrograma Interinstitucional de Pós-Graduação em Ciências Fisiológicas - PIPGCFUFSCarAttribution-NonCommercial-NoDerivs 3.0 Brazilhttp://creativecommons.org/licenses/by-nc-nd/3.0/br/info:eu-repo/semantics/openAccessEstresseEstresse de restriçãoCardiovascularNúcleo medial da amídalaAnsiedadeAngiotensinaStressRestraint stressMedial amygdaloid nucleusAnxietyAngiotensinCIENCIAS BIOLOGICAS::FARMACOLOGIACIENCIAS BIOLOGICAS::FISIOLOGIAEnvolvimento de neurotransmissões angiotensinérgicas no núcleo medial da amídala nas respostas cardiovasculares e ansiogênica ao estresse de restrição em ratosInvolvement of angiotensinergic neurotransmission in the medial amygdaloid nucleus in cardiovascular and anxiogenic responses to restraint stress in ratsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesis60060065604e0e-ddb0-417b-af11-12d9af9d2db3reponame:Repositório Institucional da UFSCARinstname:Universidade Federal de São Carlos (UFSCAR)instacron:UFSCARORIGINALTESE FINAL.pdfTESE FINAL.pdfTese finalapplication/pdf3460451https://repositorio.ufscar.br/bitstream/ufscar/13362/4/TESE%20FINAL.pdf8db0fbecb99e5efd486d84e0d72c9153MD54modelo-carta-comprovante.pdfmodelo-carta-comprovante.pdfCarta comprovanteapplication/pdf226376https://repositorio.ufscar.br/bitstream/ufscar/13362/2/modelo-carta-comprovante.pdfa0a977d9b66f6b23309289be4308751cMD52CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8811https://repositorio.ufscar.br/bitstream/ufscar/13362/5/license_rdfe39d27027a6cc9cb039ad269a5db8e34MD55TEXTTESE FINAL.pdf.txtTESE FINAL.pdf.txtExtracted texttext/plain192542https://repositorio.ufscar.br/bitstream/ufscar/13362/6/TESE%20FINAL.pdf.txt4c4b57bceaa72c4eaeb4a0a711f992c5MD56modelo-carta-comprovante.pdf.txtmodelo-carta-comprovante.pdf.txtExtracted texttext/plain1317https://repositorio.ufscar.br/bitstream/ufscar/13362/8/modelo-carta-comprovante.pdf.txt124f4206131f3c0bd55f1cdfd26f6e1bMD58THUMBNAILTESE FINAL.pdf.jpgTESE FINAL.pdf.jpgIM Thumbnailimage/jpeg6218https://repositorio.ufscar.br/bitstream/ufscar/13362/7/TESE%20FINAL.pdf.jpg82f198c08a2f37d120c83e6a3290b271MD57modelo-carta-comprovante.pdf.jpgmodelo-carta-comprovante.pdf.jpgIM Thumbnailimage/jpeg13970https://repositorio.ufscar.br/bitstream/ufscar/13362/9/modelo-carta-comprovante.pdf.jpg4f8b96add9a3e3f7f859f426582b3baeMD59ufscar/133622023-09-18 18:32:03.185oai:repositorio.ufscar.br:ufscar/13362Repositório InstitucionalPUBhttps://repositorio.ufscar.br/oai/requestopendoar:43222023-09-18T18:32:03Repositório Institucional da UFSCAR - Universidade Federal de São Carlos (UFSCAR)false
dc.title.por.fl_str_mv Envolvimento de neurotransmissões angiotensinérgicas no núcleo medial da amídala nas respostas cardiovasculares e ansiogênica ao estresse de restrição em ratos
dc.title.alternative.eng.fl_str_mv Involvement of angiotensinergic neurotransmission in the medial amygdaloid nucleus in cardiovascular and anxiogenic responses to restraint stress in rats
title Envolvimento de neurotransmissões angiotensinérgicas no núcleo medial da amídala nas respostas cardiovasculares e ansiogênica ao estresse de restrição em ratos
spellingShingle Envolvimento de neurotransmissões angiotensinérgicas no núcleo medial da amídala nas respostas cardiovasculares e ansiogênica ao estresse de restrição em ratos
Costa-Ferreira, Willian
Estresse
Estresse de restrição
Cardiovascular
Núcleo medial da amídala
Ansiedade
Angiotensina
Stress
Restraint stress
Medial amygdaloid nucleus
Anxiety
Angiotensin
CIENCIAS BIOLOGICAS::FARMACOLOGIA
CIENCIAS BIOLOGICAS::FISIOLOGIA
title_short Envolvimento de neurotransmissões angiotensinérgicas no núcleo medial da amídala nas respostas cardiovasculares e ansiogênica ao estresse de restrição em ratos
title_full Envolvimento de neurotransmissões angiotensinérgicas no núcleo medial da amídala nas respostas cardiovasculares e ansiogênica ao estresse de restrição em ratos
title_fullStr Envolvimento de neurotransmissões angiotensinérgicas no núcleo medial da amídala nas respostas cardiovasculares e ansiogênica ao estresse de restrição em ratos
title_full_unstemmed Envolvimento de neurotransmissões angiotensinérgicas no núcleo medial da amídala nas respostas cardiovasculares e ansiogênica ao estresse de restrição em ratos
title_sort Envolvimento de neurotransmissões angiotensinérgicas no núcleo medial da amídala nas respostas cardiovasculares e ansiogênica ao estresse de restrição em ratos
author Costa-Ferreira, Willian
author_facet Costa-Ferreira, Willian
author_role author
dc.contributor.authorlattes.por.fl_str_mv http://lattes.cnpq.br/1826719696228199
dc.contributor.author.fl_str_mv Costa-Ferreira, Willian
dc.contributor.advisor1.fl_str_mv Crestani, Carlos Cesar
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/1117432571971568
dc.contributor.authorID.fl_str_mv c714f15c-534b-4a9f-a5af-9f7c04a4bc10
contributor_str_mv Crestani, Carlos Cesar
dc.subject.por.fl_str_mv Estresse
Estresse de restrição
Cardiovascular
Núcleo medial da amídala
Ansiedade
Angiotensina
topic Estresse
Estresse de restrição
Cardiovascular
Núcleo medial da amídala
Ansiedade
Angiotensina
Stress
Restraint stress
Medial amygdaloid nucleus
Anxiety
Angiotensin
CIENCIAS BIOLOGICAS::FARMACOLOGIA
CIENCIAS BIOLOGICAS::FISIOLOGIA
dc.subject.eng.fl_str_mv Stress
Restraint stress
Medial amygdaloid nucleus
Anxiety
Angiotensin
dc.subject.cnpq.fl_str_mv CIENCIAS BIOLOGICAS::FARMACOLOGIA
CIENCIAS BIOLOGICAS::FISIOLOGIA
description Limbic structures participate in the control of physiological responses related to stress, and the medial amigdaloid nucleus (MeA) has been demonstrated as an area of the central nervous system involved in the control these responses. The angiotensin II, acting on the AT1 receptor, has been shown to be an important signaling mechanism in the central nervous system involved in the etiology of behavioral changes and in the physiological adjustments observed during aversive situations, whereas the AT2 receptor and the angiotensin 1-7/Mas receptor neutranmission acts as a mechanism against regulation of the AT1 receptor. Thus, the hypothesis of our work was that cardiovascular and anxiogenic changes to restraint stress (RS) are modulated by angiotensin II/ AT1 receptor, AT2 and angiotensin 1-7 / Mas receptor neurotransmission in the AMe. In the characterization the role of angiotensinergic neurotransmissions in the MeA in the baroreflex control activity in non-stressed animals indicated that the AT2 receptor in MeA plays an inhibitory role in the tachycardia reflex response, but without affecting bradycardia reflex; whereas the Mas receptor has a facilitating influence on both tachycardia and bradycardia reflex. In experiments on cardiovascular function of exposure to a 10-days of RS, this protocol caused an increase in arterial pressure baseline, facilitated tachycardic reflex and impaired spontaneous baroreflex activity. The animals treated with losartan attenuated tachycardia reflex, whereas the other changes were not affected by treatments. In the experiment comparing the effects of the MeA pharmacological treatments with angiotensinergic receptors agonists and antagonists on cardiovascular responses during an acute session and the 10th RS session, we found that repeated exposure to RS abolished facilitation of tachycardic response caused by the treatment of the MeA with angiotensin II and losartan in acute stressed animals. The tachycardic reduction caused by A-779 and the pressor response in animals treated with PD123319 in animals that were acutely stressed, was inhibited after repeated exposure to RS. In addition, repeated exposure to RS reversed the reduction in tachycardic response caused by MeA treatment with PD123319 seen in acutely stressed animals. Was not observed effect on facilitation of the tachycardic response after repeated exposure to RS by angiontensin 1-7 microinjection in the MeA. The reduction in the skin's tail temperature was greater in chronically stressed animals, and only treatment with PD123319 inhibited this facilitation. In the anxiogenic response, animals that went through an acute session showed behavioral of the anxiogenic type, and treatments with angiotensin II, losartan and angiotensin 1-7 inhibited this effect. Anxiogenic effect was also observed 24h after the 9th restraint session, and without additional five minutes after the 10th restraint session. In addition, the pharmacological treatments of the MeA did not cause any behavioral changes in the EPM in animals repeatedly exposed to RS. Finally, we identified that repeated exposure to RS increased the expression of the AT1 receptor and decreased the expression of the Mas receptor in the MeA. In short, our data support an involvement of RAS present in MeA in the control of cardiovascular and behavioral responses to stress, and this control seems to beinfluenced by previous experience with the stressor.
publishDate 2020
dc.date.accessioned.fl_str_mv 2020-10-22T14:28:48Z
dc.date.available.fl_str_mv 2020-10-22T14:28:48Z
dc.date.issued.fl_str_mv 2020-09-04
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv COSTA-FERREIRA, Willian. Envolvimento de neurotransmissões angiotensinérgicas no núcleo medial da amídala nas respostas cardiovasculares e ansiogênica ao estresse de restrição em ratos. 2020. Tese (Doutorado em Ciências Fisiológicas) – Universidade Federal de São Carlos, São Carlos, 2020. Disponível em: https://repositorio.ufscar.br/handle/ufscar/13362.
dc.identifier.uri.fl_str_mv https://repositorio.ufscar.br/handle/ufscar/13362
identifier_str_mv COSTA-FERREIRA, Willian. Envolvimento de neurotransmissões angiotensinérgicas no núcleo medial da amídala nas respostas cardiovasculares e ansiogênica ao estresse de restrição em ratos. 2020. Tese (Doutorado em Ciências Fisiológicas) – Universidade Federal de São Carlos, São Carlos, 2020. Disponível em: https://repositorio.ufscar.br/handle/ufscar/13362.
url https://repositorio.ufscar.br/handle/ufscar/13362
dc.language.iso.fl_str_mv por
language por
dc.relation.confidence.fl_str_mv 600
600
dc.relation.authority.fl_str_mv 65604e0e-ddb0-417b-af11-12d9af9d2db3
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivs 3.0 Brazil
http://creativecommons.org/licenses/by-nc-nd/3.0/br/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivs 3.0 Brazil
http://creativecommons.org/licenses/by-nc-nd/3.0/br/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Universidade Federal de São Carlos
Câmpus São Carlos
dc.publisher.program.fl_str_mv Programa Interinstitucional de Pós-Graduação em Ciências Fisiológicas - PIPGCF
dc.publisher.initials.fl_str_mv UFSCar
publisher.none.fl_str_mv Universidade Federal de São Carlos
Câmpus São Carlos
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFSCAR
instname:Universidade Federal de São Carlos (UFSCAR)
instacron:UFSCAR
instname_str Universidade Federal de São Carlos (UFSCAR)
instacron_str UFSCAR
institution UFSCAR
reponame_str Repositório Institucional da UFSCAR
collection Repositório Institucional da UFSCAR
bitstream.url.fl_str_mv https://repositorio.ufscar.br/bitstream/ufscar/13362/4/TESE%20FINAL.pdf
https://repositorio.ufscar.br/bitstream/ufscar/13362/2/modelo-carta-comprovante.pdf
https://repositorio.ufscar.br/bitstream/ufscar/13362/5/license_rdf
https://repositorio.ufscar.br/bitstream/ufscar/13362/6/TESE%20FINAL.pdf.txt
https://repositorio.ufscar.br/bitstream/ufscar/13362/8/modelo-carta-comprovante.pdf.txt
https://repositorio.ufscar.br/bitstream/ufscar/13362/7/TESE%20FINAL.pdf.jpg
https://repositorio.ufscar.br/bitstream/ufscar/13362/9/modelo-carta-comprovante.pdf.jpg
bitstream.checksum.fl_str_mv 8db0fbecb99e5efd486d84e0d72c9153
a0a977d9b66f6b23309289be4308751c
e39d27027a6cc9cb039ad269a5db8e34
4c4b57bceaa72c4eaeb4a0a711f992c5
124f4206131f3c0bd55f1cdfd26f6e1b
82f198c08a2f37d120c83e6a3290b271
4f8b96add9a3e3f7f859f426582b3bae
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFSCAR - Universidade Federal de São Carlos (UFSCAR)
repository.mail.fl_str_mv
_version_ 1813715622441254912